AIRLINK 74.29 Increased By ▲ 0.29 (0.39%)
BOP 4.95 Decreased By ▼ -0.07 (-1.39%)
CNERGY 4.37 Decreased By ▼ -0.05 (-1.13%)
DFML 38.80 Decreased By ▼ -0.40 (-1.02%)
DGKC 84.82 Decreased By ▼ -1.27 (-1.48%)
FCCL 21.21 Decreased By ▼ -0.44 (-2.03%)
FFBL 34.12 Increased By ▲ 0.11 (0.32%)
FFL 9.70 Decreased By ▼ -0.22 (-2.22%)
GGL 10.42 Decreased By ▼ -0.14 (-1.33%)
HBL 113.00 Decreased By ▼ -0.89 (-0.78%)
HUBC 136.20 Increased By ▲ 0.36 (0.27%)
HUMNL 11.90 No Change ▼ 0.00 (0%)
KEL 4.71 Decreased By ▼ -0.13 (-2.69%)
KOSM 4.44 Decreased By ▼ -0.09 (-1.99%)
MLCF 37.65 Decreased By ▼ -0.62 (-1.62%)
OGDC 136.20 Increased By ▲ 1.35 (1%)
PAEL 25.10 Decreased By ▼ -1.25 (-4.74%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.71 Increased By ▲ 0.03 (0.45%)
PPL 122.10 Decreased By ▼ -0.90 (-0.73%)
PRL 26.65 Decreased By ▼ -0.04 (-0.15%)
PTC 13.93 Decreased By ▼ -0.40 (-2.79%)
SEARL 57.22 Decreased By ▼ -1.90 (-3.21%)
SNGP 67.60 Decreased By ▼ -1.90 (-2.73%)
SSGC 10.25 Decreased By ▼ -0.08 (-0.77%)
TELE 8.40 Decreased By ▼ -0.10 (-1.18%)
TPLP 11.13 Decreased By ▼ -0.10 (-0.89%)
TRG 62.81 Decreased By ▼ -2.04 (-3.15%)
UNITY 26.50 Increased By ▲ 0.25 (0.95%)
WTL 1.35 Increased By ▲ 0.01 (0.75%)
BR100 7,810 Decreased By -40.3 (-0.51%)
BR30 25,150 Decreased By -186.4 (-0.74%)
KSE100 74,957 Decreased By -250.1 (-0.33%)
KSE30 24,083 Decreased By -59.5 (-0.25%)
Technology

Lab-grown blood vessels built from patient’s cells to make dialysis easier

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers a
Published April 1, 2019

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers are trying to change by growing human blood vessels in lab by the patient’s cells in order to make dialysis easier.

Researchers from Humacyte Inc., Duke University and Yale have created lab-grown human blood vessels from the patient’s own cells, which will replace synthetic polymers and donor tissues that carry risks of inflammation and immune system rejection.

The process of dialysis, as per Engadget, mimics some few of the kidney’s main functions, but it requires a machine that pulls out blood from a blood vessel, filters it and pumps it back into the body. An extra blood vessel, either synthetic or donated, is implanted into the patient’s arm that channels blood into the dialysis machine.

Newly created urea sorbent paves way for wearable artificial kidneys

In contrast to usual dialysis, the new method, which is already heading into clinical trials, would allow the patient’s own cells to create the extra blood vessel to be implanted in the arm.

The researchers lined a biodegradable polymer tube with vascular cells from a deceased donor. For eight weeks, the cells multiplied and formed a new tube while the polymer scaffolding broke down. The team then took the cellular tube and implanted it to the patient’s arm. The patients’ cells migrated into the tubes and multiplied to create mature blood vessels.

Out of 60 patients that participated, 13 showed that blood vessels developed into multi-layered tissues that self-healed after injury, effectively becoming like the person’s own blood vessels, reported New Scientist.

Moreover, these bioengineered vessels also showed no signs of scarring or inflammatory reactions. The researchers further hope to create large numbers of engineered blood vessels that doctors can essentially obtain ‘off-the-shelf’ for using in patients with various vascular diseases, including heart disease.

Copyright Business Recorder, 2019

Comments

Comments are closed.